Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 18, 2007, Pages 6012-6017

  Bozdaǧ Dündar, Oya ^a   Özgen, Özen ^b   Menteşe, Arzu ^a   Altanlar, Nurten ^a   Atli, Onur ^a   Kendi, Engin ^b   Ertan, Rahmiye ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Single X ray structure; Thiazole derivatives; Thiazolidine 2,4 diones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 (2 PHENYL 2 OXOETHYL) 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL) THIAZOLIDINE 2,4 DIONE; 3 [2 (2,4 DICHLOROPHENYL) 2 OXOETHYL] 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL)THIAZOLIDINE 2,4 DIONE; 3 [2 (4 BROMOPHENYL) 2 OXOETHYL] 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL) THIAZOLIDINE 2,4 DIONE; 3 [2 (4 CHLOROPHENYL) 2 OXOETHYL] 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL) THIAZOLIDINE 2,4 DIONE; 3 [2 (4 FLUOROPHENYL) 2 OXOETHYL] 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL) THIAZOLIDINE 2,4 DIONE; 3 [2 (4 NITROPHENYL) 2 OXOETHYL] 5 (2,4 DICHLOROTHIAZOL 5 YLMETHYLENYL) THIAZOLIDINE 2,4 DIONE; AMPICILLIN; CIPROFLOXACIN; MICONAZOLE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CHIRALITY; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; X RAY DIFFRACTION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; ESCHERICHIA COLI; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; STAPHYLOCOCCUS AUREUS; THIAZOLIDINES;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 34447628509     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.06.049     Document Type: Article

References (29)

1. Todar's Online Textbook of Bacteriology. http://www.textbookofbacteriology.net/.
2. Hooper D.C. Clin. Infect. Dis. 33 (2001) 5157
3. Galimand M., Courvalin P., and Lambert T. Antimicrob. Agents Chemother. 47 (2003) 2565
4. Tenover F.C. Clin. Infect. Dis. 33 (2001) S108
5. Leclercq R., and Courvalin P. Antimicrob. Agents Chemother. 46 (2002) 2727
6. Nagai K., Davies T.A., Jacobs M.R., and Appelbaum P.C. Antimicrob. Agents Chemother. 46 (2002) 1273
7. Fung-Tomc J.C., Clark J., Minassian B., Pucci M., Tsai Y.H., Gradelski E., Lamb L., Medina I., Huczko E., Kolek B., Chaniewski S., Ferraro C., Washo T., and Bonner D.P. Antimicrob. Agents Chemother. 46 (2002) 971
8. Chopra I. Curr. Opin. Pharmacol. 1 (2001) 464
9. Nagano R., Shibata K., Adachi Y., Imamura H., Hashizume T., and Morishima H. Antimicrob. Agents Chemother. 44 (2000) 489
10. Capobianco J.O., Cao Z., Shortridge V.D., Ma Z., Flamm R.K., and Zhong P. Antimicrob. Agents Chemother. 44 (2000) 1562
11. Choudhry A.E., Mandichak T.L., Broskey J.P., Egolf R.W., Kinsland C., Begley T.P., Seefeld M.A., Ku T.W., Brown J.R., Zalacain M., and Ratnam K. Antimicrob. Agents Chemother. 47 (2003) 2051
12. Colca J.R., McDonal W.G., Waldon D.J., Thomasco L.M., Gadwood R.C., Lund E.T., Cavey G.S., Mathews W.R., Adams L.D., Cecil E.T., Pearson J.D., Bock J.H., Mott J.E., Shinabarger D.L., Xiong L., and Mankin A.S. J. Biol. Chem. 278 (2003) 21972
13. Oliva B., Miller K., Caggiano N., O'Neill A.J., Cuny G.D., Hoemann M.Z., Hauske J.R., and Chopra I. Antimicrob. Agents Chemother. 47 (2003) 458
14. Nasr M.N., Gineinah M.M., and El-Bendary E.R. Arch. Pharm. 336 (2003) 560
15. DeLima M.C.A., Costa D.L.B., Goes A.J.S., Galdino S.L., Pitta I.R., and Luu-Duc C. Pharmazie 47 (1992) 182
16. Labouta I.M., Salama H.M., Eshba N.H., Kader O., and El-Chrbini E. Eur. J. Med. Chem. 22 (1987) 485
17. Sup R.C., Sup R.Y., and Bang C.W. Korean J. Med. Chem. 5 (1995) 72
18. Agarwal N., Kumar S., Srivastava A.K., and Sarkar P.C. Ind. J. Het. Chem. 6 (1997) 291
19. Ceylan-Ünlüsoy M., Bozdaǧ-Dündar O., Altanlar N., and Ertan R. Turk J. Chem. 30 (2006) 355
20. Bozdaǧ-Dündar O., Ceylan-Ünlüsoy M., Verspohl E.J., and Ertan R. Arzneim.-Forsch. Drug Res. 56 (2006) 621
21. Athmani S., Farhat M.F., and Iddon B. J. Chem. Soc., Perkin Trans. 1 (1992) 973
22. Tan S.F., Ang K.P., and Fong Y.Y. J. Chem. Soc., Perkin Trans. 2 12 (1986) 1941
23. Albuquerque J.F.C., Albuquerque A., Azevedo C.C., Thomasson F., Galdino S.L., Chantarel J., Catanho M.T.J., Pitta I.R., and Luu-Duc C. Pharmazie 50 (1995) 387
24. Vögeli U., and Philipsborn W. Helv. Chim. Acta 61 (1978) 607
25. Bruno G., Costantino L., Curinga C., Maccari R., Monforte F., Nicolo F., Ottana R., and Vigorita M.G. Bioorg. Med. Chem. 10 (2002) 1077
26. Ispida T., In Y., Inoue M., Tanaka C., and Hamanaka N. J. Chem. Soc., Perkin Trans. (1990) 1085
27. NCCLS: Method for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th ed. Approved Standard M7: A5. Villanova, PA, NCCLS, 2000.
28. Salama H.M., Labouta I.M., and Moustafa M.A. Alex. J. Pharm. Sci. 4 (1990) 44
29. De Lima J.G., Perrissin M., Chantegrel J., Luu-Duc C., Rousseau A., and Narcisse G. Arzneim.-Forsch. Drug Res. 44 (1994) 831